This study examined the effect of aspirin on prostate cancer mortality.

This study reviewed evidence on the use of medication and supplements for additional medical conditions on prostate cancer mortality. Authors concluded that commonly used medications and supplements can influence prognosis among prostate cancer patients. 

This study compared intermittent versus continuous androgen deprivation therapy (ADT) for localized (confined) prostate cancer due to prostate-specific antigen (PSA) elevation after radiotherapy. Main findings: Intermittent ADT was not inferior compared to continuous therapy with respect to survival. However, some quality of life measures, such as fatigue, urinary problems, hot flashes, libido and erectile function, showed some improvement.

The authors determined the effect of hormone therapy on hot flash interference in prostate cancer patients. 

This study aimed to see if low vitamin D levels were related to erectile dysfunction (ED). The study found that low vitamin D was associated with higher levels of ED in men.

This article reviewed information on a number of neutraceuticals that may potentially be used for the prevention or treatment of prostate cancer.

The present study evaluated the effects of hormonal therapy drugs on cardiovascular events in patients with prostate cancer. 

This study examined whether there is a link between the amount of testosterone in the prostate and the severity of the cancer.

The authors aimed to evaluate the use of Gleason scores in predicting the outlook of metastatic prostate cancer.

This study analyzed the association between cigarette smoking and prostate cancer outcomes.